Gilead Sciences (GILD) Stock Price, Quote, News & History | Benzinga

Gilead Sciences Inc (GILD) Stock Price, Quote, News & History

GILDNASDAQ

Trade with Public

Trade with Public

$134.36

3.862.96%

At close: May 22, 5:00 PM EST

$134.36

N/A

After Hours: May 22, 4:00 PM EST

M&A: Tubulis GmbH was acquired by Gilead Sciences (GILD) on Thursday, May 21, 2026 for $3.15B paid in cash

OverviewNews Earnings Options Guidance Dividends Analyst Ratings Insider Trades Short Interest Government Trades Stock Report

Key Statistics

Open

$131.57

Close

$134.36

Volume / Avg.

5.97M / 6.12M

Day Range

$131.12 - $134.52

52 Wk Range

104.46 - 157.29

Market Cap

$166.82B

P/E Ratio

17.76

Dividend Yield

2.51%

Exchange

NASDAQ

RSI

53

Short Interest

1.86%

Days to Cover

4.06

Recent Gilead Sciences, Inc News

Nasdaq Tops 29,000 Records, Micron Soars 13%: Stock Market Today

Nasdaq jumps 1.6% to record highs Friday as semiconductor rally and stronger-than-expected April payrolls overshadow ongoing Strait of Hormuz tensions.

Piero Cingari

Gilead Sciences Likely To Report Higher Q1 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Gilead Sciences (NASDAQ: GILD) will release Q1 earnings on May 7, with analysts expecting $1.91 EPS and $6.92B revenue. Stock closed at $136.30 on April 29.

Avi Kapoor

Tempus AI's Big Pharma AI Partnerships Are Getting Bigger And Stickier

Tempus AI (TEM) Q1 results: Revenue up 36.1% to $348.1M, beating estimates. TEM raises 2026 outlook amid strong AI & diagnostic demand.

Lekha Gupta

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

10.81B

Investing Cash Flow (TTM)

-2.61B

Financing Cash Flow (TTM)

-8.56B

Free Cash Flow (TTM)

10.23B

Capital Expenditure (TTM)

-576.00M

Net Change in Cash (TTM)

-360.00M

Analyst Trends and Forecast

6

Jan

5

1

Feb

1

Mar

2

Apr

2

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.6

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$181.35B

PE Ratio (TTM)

17.76

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

5.50

PB Ratio (TTM)

6.89

Earnings Yield % (TTM)

5.63%

Earnings Yield % (FWD)

-0.53%

EV / EBITDA (TTM)

12.19

Price / EBITDA (TTM)

11.30

Price / Free Cash Flow (TTM)

15.99

Book Value / Share

$18.94

Company Debt

Total Debt

$22.17B

LT Debt

$20.86B

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$2.79B

Total Cash

$7.63B

Debt to Equity

0.94

Issuance of Debt (TTM)

-$2.79B

Repayment of Debt (TTM)

-$2.79B

Key Statistics

Open

$131.57

Close

$134.36

Volume / Avg.

5.97M / 6.12M

Day Range

$131.12 - $134.52

52 Wk Range

104.46 - 157.29

Market Cap

$166.82B

P/E Ratio

17.76

Dividend Yield

2.51%

Exchange

NASDAQ

RSI

53

Short Interest

1.86%

Days to Cover

4.06

About

Sector

Health Care

Industry

Biotechnology

Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Soval...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

Q

How do I buy Gilead Sciences (GILD) stock?

A

You can purchase shares of Gilead Sciences (NASDAQ:GILD) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Gilead Sciences (GILD) competitors?

A

There are no as such competitors for Gilead Sciences.

Q

What is the forecast, or price target, for Gilead Sciences (GILD) stock?

A

Gilead Sciences has a consensus price target of $133.27.

Q

What is the current price for Gilead Sciences (GILD)?

A

The stock price for Gilead Sciences (NASDAQ: GILD) is $134.36 last updated May 22, 2026 at 4:00 PM EDT.

Q

Does Gilead Sciences (GILD) pay a dividend?

A

There are no upcoming dividends for Gilead Sciences.

Q

When is Gilead Sciences (NASDAQ:GILD) reporting earnings?

A

Gilead Sciences does not have any upcoming earnings scheduled.

Q

Is Gilead Sciences (GILD) going to split?

A

There is no upcoming split for Gilead Sciences.

Q

What sector and industry does Gilead Sciences (GILD) operate in?

A

Gilead Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.